VNRX (VolitionRX) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VNRX VolitionRX Ltd VNRX
54 GF Score
Price $0.58
GF Value $17.52
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is VolitionRX Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

VNRX
54GF Score
VolitionRX Ltd VNRX
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is VolitionRX (VNRX) Overvalued in 2026?

Based on GuruFocus' analysis, VolitionRX stock appears to be undervalued. The current stock price of $0.58 is trading 96.7% below its estimated GF Value™ of $17.52. GuruFocus considers VolitionRX to be Possible Value Trap.

Key valuation signals for VNRX:

  • Interest Received:
  • GF Value™: $17.52 vs. price of $0.58 (96.7% below fair value)
  • GF Score™: 54/100 with 8 warning signs

No single metric tells the full story. See the VNRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

VolitionRX Business Description

Address 1489 West Warm Springs Road, Suite 110, Henderson, NV, USA, 89014
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.
54GF Score

Get the complete analysis for VNRX

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.58
Price
$17.52
GF Value